Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms : a sham-controlled, randomized multicenter trial

Copyright © 2015 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved..

BACKGROUND: Investigators are urgently searching for options to treat negative symptoms in schizophrenia because these symptoms are disabling and do not respond adequately to antipsychotic or psychosocial treatment. Meta-analyses based on small proof-of-principle trials suggest efficacy of repetitive transcranial magnetic stimulation (rTMS) for the treatment of negative symptoms and call for adequately powered multicenter trials. This study evaluated the efficacy of 10-Hz rTMS applied to the left dorsolateral prefrontal cortex for the treatment of predominant negative symptoms in schizophrenia.

METHODS: A multicenter randomized, sham-controlled, rater-blinded and patient-blinded trial was conducted from 2007-2011. Investigators randomly assigned 175 patients with schizophrenia with predominant negative symptoms and a high-degree of illness severity into two treatment groups. After a 2-week pretreatment phase, 76 patients were treated with 10-Hz rTMS applied 5 days per week for 3 weeks to the left dorsolateral prefrontal cortex (added to the ongoing treatment), and 81 patients were subjected to sham rTMS applied similarly.

RESULTS: There was no statistically significant difference in improvement in negative symptoms between the two groups at day 21 (p = .53, effect size = .09) or subsequently through day 105. Also, symptoms of depression and cognitive function showed no differences in change between groups. There was a small, but statistically significant, improvement in positive symptoms in the active rTMS group (p = .047, effect size = .30), limited to day 21.

CONCLUSIONS: Application of active 10-Hz rTMS to the left dorsolateral prefrontal cortex was well tolerated but was not superior compared with sham rTMS in improving negative symptoms; this is in contrast to findings from three meta-analyses.

Medienart:

E-Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:77

Enthalten in:

Biological psychiatry - 77(2015), 11 vom: 01. Juni, Seite 979-88

Sprache:

Englisch

Beteiligte Personen:

Wobrock, Thomas [VerfasserIn]
Guse, Birgit [VerfasserIn]
Cordes, Joachim [VerfasserIn]
Wölwer, Wolfgang [VerfasserIn]
Winterer, Georg [VerfasserIn]
Gaebel, Wolfgang [VerfasserIn]
Langguth, Berthold [VerfasserIn]
Landgrebe, Michael [VerfasserIn]
Eichhammer, Peter [VerfasserIn]
Frank, Elmar [VerfasserIn]
Hajak, Göran [VerfasserIn]
Ohmann, Christian [VerfasserIn]
Verde, Pablo E [VerfasserIn]
Rietschel, Marcella [VerfasserIn]
Ahmed, Raees [VerfasserIn]
Honer, William G [VerfasserIn]
Malchow, Berend [VerfasserIn]
Schneider-Axmann, Thomas [VerfasserIn]
Falkai, Peter [VerfasserIn]
Hasan, Alkomiet [VerfasserIn]

Links:

Volltext

Themen:

Brain stimulation
Evidence-based psychiatry
Journal Article
Multicenter Study
Negative symptoms
Randomized Controlled Trial
Randomized controlled trial
Repetitive transcranial magnetic stimulation
Research Support, Non-U.S. Gov't
Schizophrenia

Anmerkungen:

Date Completed 26.01.2016

Date Revised 11.05.2015

published: Print-Electronic

ClinicalTrials.gov: NCT00783120

Citation Status MEDLINE

doi:

10.1016/j.biopsych.2014.10.009

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM245280871